Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals Ltd (524632): company summary
Shukra Pharmaceuticals Ltd (524632) is a micro-cap Healthcare company valued at ₹2,404 crore operating in Pharmaceuticals on the NSE and BSE.
Shukra Pharmaceuticals Ltd (524632) is a micro-cap Healthcare company valued at ₹2,404 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -1.3% a year over three years; profit grew 70.5% a year, ahead of revenue — margins are expanding. Return on equity is 28.9%.
- Valuation multiples
- The stock trades at 236.1 times earnings, a premium to the Healthcare median of 32.5, 23.81 times book value. It yields 0.0%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (10.0) and quality (7.5), but held back by valuation (0.0). Growth looks strong at 10.0, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Profit compounding 71% a year
- Revenue compounding 39% a year
- Healthy net margin (30%)
- Valuation is weak (0.0/10)
- Expensive at 200× earnings
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Shukra Pharmaceuticals Ltd’s valuation
Free deep-dive tools · no sign-up
Shukra Pharmaceuticals Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Shukra Pharmaceuticals Ltd with peers
Related tools & concepts
Value Shukra Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.

